Registration Closing Soon for 2nd Digital Exosome Based Therapeutic Development Summit

We are only two weeks away from the much-anticipated 2nd Digital Exosome Based Therapeutic Development Summit (November 11-12). Bringing together industry leaders and newcomers in the field, this is the only industry-dedicated meeting focused on advancing and scaling exosome-based therapeutics into a clinical and commercial reality.

At this unique meeting you’ll be able to experience:

2 Days of Learning | 80+ Expert Industry Attendees | 20 Focused Case Studies | 4+ Dedicated Networking Hours

… and all of this 100% dedicated to the challenges and innovation currently taking place in exosome therapeutics as preparations are underway for the first clinical trials.

Highlights of the 2020 agenda

With 20+ speakers and 2 days of unrivaled in-depth content addressing your most pressing questions, join your peers to discuss:

  • Harnessing cell biology to engineer and design clinically effective exosome platforms with Xosomix, Brainstorm Cell Therapeutics & more
  • Achieving consistent clinical performance of exosome-based therapies as manufacturing is scaled with Codiak Biosciences & ReNeuron
  • Clinical utility of exosome products loaded with gene therapy & siRNA across neuro, cardiovascular & immunological disease with Anjarium Biosciences, Aruna Bio & Harvard Medical School

  • Innovation in the applications of exosomes for COVID-19 vaccines with Capricor Therapeutics

This does not cover half the event content… Access the digital event guide here to see the full speaker faculty and session details.

​​​​​​Confirmed Attendees

We have been blown away by the response from the industry. So much so, we wanted to show you just a snippet of the audience we have built!

  • Aegle Therapeutics
  • Alnylam Pharmaceuticals
  • Astellas Pharma Inc
  • AstraZeneca
  • Boehringer Ingelheim
  • Celularity
  • Codiak Biosciences
  • Direct Biologics
  • Evox Therapeutics Ltd.

 

  • Exogenus Therapeutics
  • Exonox Biosciences
  • Exopharm Ltd
  • GenCure
  • ILIAS Biologics Inc.
  • InnoCan Pharma
  • Inserm
  • Korea Institute of Science & Technology
  • Kourion Therapeutics

 

  • Mantra Bio
  • Merck
  • NeoBiosis, LLC
  • NOVADIP Biosciences S.A.
  • The Scripps Research Institute
  • Vertex Pharmaceuticals Inc.
  • Vesigen Therapeutics
  • VivaZome Therapeutics
  • VIVEX Biologics

And many more… Get in touch to see all companies and job titles of confirmed attendees.

Don’t miss out! Limited passes remain 
– register your attendance now.

Contact

General Enquiries & Registration Assistance
Aiden Jordan
Delegate Acquisition Manager
Hanson Wade
(+1) 617 455 4188
info@hansonwade.com

Partnership Opportunities
Adam Mayar
Partnerships Director
Hanson Wade
(+1) 617 455 4188
sponsor@hansonwade.com

Comments (0)
Add Comment